Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03372837 |
|---|---|
| Brief Title: | Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma |
| First Submitted : | December 10, 2017 |
| First Submitted that Met QC Criteria : | December 10, 2017 |
| First Posted : | December 14, 2017 |
| Last Update Submitted that Met QC Criteria : | April 13, 2023 |
| Last Update Posted : | April 18, 2023 |